Süleyman Sunkak
Kayseri, Kocasinan, 38080, Turkey (Türkiye)
NCT Number: NCT04859036
In this study; we evaluated the heart rate variability parameters of pediatric patients whose VSDs were closed with the transcatheter method before and after, and compared with the control group.
Looking for future studies?
Notify Me56 month–136 month
All sexes
Observational
Kayseri, Kocasinan, 38080, Turkey (Türkiye)
Heart rate variability (HRV) is a sign of cardiac autonomic nervous system. Evaluation of HRV in pediatric ventricular septal defect (VSD) cases before and after transcatheter closure will enlighten us in terms of cardiac autonomic control.
Methods: 19 VSD cases treated with transcatheter closure method and 18 healthy children were enrolled in the study. 24 hours Holter rhythm monitorization was applied to all patients before closure of VSD and to the control group. In the patient group, Holter rhythm monitorization was repeated in the third months. HRV parameters were obtained from Cardio Scan Premier 12® program. Frequency domain (Total power, VLF, LF, HF, LF/HF ratio) and time domain analysis (SDNN, SDANN, SDNNi, pNN50, rMSSD) were applied.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24 hours
Time Domain analysis:
After ectopic beats and artifacts were excluded, the following indices were calculated for time domian analysis in the whole Holter recording.
Frequency domain analysis:
We determined spectral power over three frequency.
Kayseri City Hospital
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04667455
Aortopulmonary Septal Defect, Aortopulmonary Window
Lund, Skåne County, Sweden
View Trial DetailsNCT06298344
Atrial Septal Defect, Avitaminosis
Medan, North Sumatera, Indonesia
View Trial DetailsNCT05688670
Atrial Septal Defect, Cardiovascular Abnormalities
Durham, North Carolina, United States
View Trial DetailsNCT05939713
Cardiovascular Abnormalities, Cardiovascular Diseases
Kaohsiung City, Taiwan
View Trial Details